Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin

Vaccine

Volumn 20, Issue 11-12, 2002, Pages 1653-1659

  Sheoran, A S ^a   Artiushin, S ^a   Timoney, J F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cholera toxin; Equine antibody isotypes; Intranasal immunization; SeM peptide

Indexed keywords

CHOLERA TOXIN B A2; CHOLERA TOXIN PROTEIN SEMF3 CONJUGATE; GANGLIOSIDE GM1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GA; IMMUNOGLOBULIN GB; PROTEIN SEM; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BLOOD ANALYSIS; CONTROLLED STUDY; HORSE; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS EQUI;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHOLERA TOXIN; HORSE DISEASES; HORSES; IMMUNITY, MUCOSAL; NASAL MUCOSA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS EQUI; VACCINES, SYNTHETIC;

EID: 0037154755     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00488-1     Document Type: Article

References (21)

1. The common mucosal immune system and current strategies for induction of immune response in external secretions
2. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines
3. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens
4. Whole cholera toxin and B sub-unit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin
5. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B sub-units
6. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B sub-unit as an adjuvant
7. Cholera toxin B sub-unit as a carrier protein to stimulate a mucosal immune response
8. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B sub-unit as an adjuvant
9. Antibody isotype responses to cholera toxin or cholera toxin B sub-unit as mucosal adjuvants in horses
10. Equine mucosal immune system: Intranasal vaccination with inactivated equine influenza virus protects from infection
11. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe
12. Strangles
13. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses
14. Regions of the protective M-like protein of Streptococcus equi recognized by serum and mucosal antibodies of convalescent horses
15. Induction of mucosal and systemic antibody specific for SeM F3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system
16. Predicting coiled coils from protein sequences
17. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B sub-unit and effects of preexisting anti-CT immunity
18. 2 domain of cholera toxin
19. Characterization of murine monoclonal antibodies recognizing opsonic, mouse-protective, chaining and mucosally relevant epitopes on the M protein of Streptococcus equi subspecies equi
20. Epidemiologic and immunologic characteristics of Streptococcus equi infection in foals
21. Mucosal nasopharyngeal immune response of the horse to protein antigens of Streptococcus equi